Medindia

X

Advanced Life Sciences to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

Wednesday, October 31, 2007 General News J E 4
Advertisement
CHICAGO, Oct. 30 Advanced Life SciencesHoldings, Inc. (Nasdaq: ADLS) today announced that it will present at theAcumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New YorkCity, which will be webcast live via streaming audio. Advanced Life Sciences'management will provide an overview and update of the Company's business.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO)

The Company's presentation will be delivered at 12:40 to 1:00PM in theSpellman room (5th Floor) with a breakout to follow from 1:00-1:20PM EasternStandard Time on Tuesday, November 6th, 2007 at The Palace Hotel in New YorkCity. The webcast can be accessed through the Investor Relations page on theAdvanced Life Sciences website, http://www.advancedlifesciences.com. Thoseinterested in listening to the presentation should log on a few minutes inadvance in order to download any software or complete any sign-in that may berequired.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in thediscovery, development and commercialization of novel drugs in the therapeuticareas of infection, cancer and respiratory diseases. The Company's leadcandidate, cethromycin, is a novel once-a-day antibiotic in late-stageclinical development for the treatment of respiratory tract infectionsincluding CAP. For more information, please visit us on the web athttp://www.advancedlifesciences.com.

Any statements contained in this presentation that relate to future plans,events or performance are forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. These forward-lookingstatements are subject to a number of risks and uncertainties that could causeactual results to differ materially from those described in theforward-looking statements. These risks and uncertainties include, amongothers, those relating to technology and product development, marketacceptance, government regulation and regulatory approval processes,intellectual property rights and litigation, dependence on collaborativerelationships, ability to obtain financing, competitive products, industrytrends and other risks identified in Advanced Life Sciences' filings with theSecurities and Exchange Commission. Advanced Life Sciences undertakes noobligation to update or alter these forward-looking statements as a result ofnew information, future events or otherwise.

SOURCE Advanced Life Sciences Holdings, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Autism, Early Intervention Pioneer to Conduct Lect...
S
Barr Receives Tentative Approval for a Generic Ver...